Kidney allograft fibrosis and atrophy early after living donor transplantation

Fernando G. Cosio, Joseph P. Grande, Timothy S. Larson, James M. Gloor, Jorge A. Velosa, Stephen C. Textor, Matthew D. Griffin, Mark D. Stegall

Research output: Contribution to journalArticlepeer-review

105 Scopus citations

Abstract

Kidney allograft failure is most often caused by chronic allograft nephropathy, a process interstitial fibrosis (GIF) and tubular atrophy (TA). We assessed the pathology of living donor (LD) grafts compared to deceased donor (DD). Included are 321 recipients (245 LD; 76 DD) with protocol biopsies the first 2 years of transplant. In LD, GIF was present in 7%, 31%, 61% and 71% of grafts at 0, 4, 12 and 24 months. TA progressed in parallel to GIF. Compared to LD, more DD grafts had GIF at time 0 (29%, p = 0.002); thereafter the incidence of GIF was similar. In LD, GIF was associated with lower glomesrular filtration rate (GFR)1year (no GIF, 62 ± 16; GIF, 49 ± 15 mL/min/m2 iothalamate clearance, p = 0.001) and reduced graft survival (HR = 2.2, p = 0.009). GIF in LD related to acute rejection (HR = 2.6, p = 0.01), polyoma nephropathy (OR = 4.4, p = 0.02) and lower levels of GFR 3 weeks post-transplant (HR = 0.961; p = 0.03, multivariate). However, GIF also developed in 53% of recipients lacking these covariates. Thus, GIF/TA develops in the majority of LD grafts, it is often mild but is associated with reduced function and survival. GIF frequently develops in the absence of risk factors. Lower GFR post-transplant identify patients at highest risk of GIF.

Original languageEnglish (US)
Pages (from-to)1130-1136
Number of pages7
JournalAmerican Journal of Transplantation
Volume5
Issue number5
DOIs
StatePublished - May 2005

Keywords

  • Chronic allograft nephropathy
  • Kidney transplant
  • Living donors
  • Protocol biopsies

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Kidney allograft fibrosis and atrophy early after living donor transplantation'. Together they form a unique fingerprint.

Cite this